The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma

A tétel rövid nézete
dc.contributor.authorHorwitz, Steven
dc.contributor.authorO'Connor, Owen A.
dc.contributor.authorPro, Barbara
dc.contributor.authorTrümper, Lorenz
dc.contributor.authorIyer, Swaminathan
dc.contributor.authorAdvani, Ranjana
dc.contributor.authorBartlett, Nancy L.
dc.contributor.authorChristensen, Jacob Haaber
dc.contributor.authorMorschhauser, Franck
dc.contributor.authorDomingo-Domenech, Eva
dc.contributor.authorRossi, Giuseppe
dc.contributor.authorKim, Won-Seok
dc.contributor.authorFeldman, Tatyana
dc.contributor.authorMenne, T.
dc.contributor.authorBelada, David
dc.contributor.authorIllés, Árpád
dc.contributor.authorTobinai, Kensei
dc.contributor.authorTsukasaki, Kunihiro
dc.contributor.authorYeh, Su-Peng
dc.contributor.authorShustov, Andrei
dc.contributor.authorHüttmann, Andreas
dc.contributor.authorSavage, Kerry J.
dc.contributor.authorYuen, Sam
dc.contributor.authorZinzani, Pier Luigi
dc.contributor.authorMiao, Harry
dc.contributor.authorBunn, V.
dc.contributor.authorFenton, Keenan
dc.contributor.authorFanale, Michelle
dc.contributor.authorPuhlmann, M.
dc.contributor.authorIllidge, Tim
dc.date.accessioned2024-04-25T13:21:17Z
dc.date.available2024-04-25T13:21:17Z
dc.date.issued2022
dc.date.oa2024-09-05
dc.date.pasync2025-08-14T23:11:01Z
dc.date.updated2024-04-25T13:21:17Z
dc.description.correctorkzs
dc.identifier.citationAnnals Of Oncology. -33 : 3 (2022), p. 288-298. -Ann. Oncol. - 0923-7534. - 1569-8041
dc.identifier.doihttp://dx.doi.org/10.1016/j.annonc.2021.12.002
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.opachttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM120740
dc.identifier.scopus85122922204
dc.identifier.urihttps://hdl.handle.net/2437/369288
dc.identifier.urlhttps://linkinghub.elsevier.com/retrieve/pii/S0923753421048754
dc.identifier.wos000755659500008
dc.languageeng
dc.rights.accessopen access article
dc.rights.ownerszerző
dc.subject.mabOrvostudományok
dc.subject.mabKlinikai orvostudományok
dc.titleThe ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma
dc.typefolyóiratcikk
dc.typeidegen nyelvű folyóiratközlemény külföldi lapban
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
FILE_UP_0_The ECHELON-2 Trial.pdf
Méret:
547.22 KB
Formátum:
Adobe Portable Document Format
Leírás:
kiadói változat
Letöltés
Gyűjtemények
Publikációs Adatbázis